Inflammatory Breast Carcinoma Morphology
Inflammatory breast carcinoma (IBC) is primarily a clinical diagnosis characterized by diffuse breast erythema, edema, and peau d'orange, with the pathognomonic histologic finding being dermal lymphovascular tumor emboli, though this feature is not required for diagnosis. 1
Clinical Morphology (Primary Diagnostic Features)
The diagnosis of IBC remains fundamentally clinical rather than purely pathological. The minimum diagnostic criteria include 1:
- Rapid onset of breast erythema, edema, and/or peau d'orange
- Warm breast with or without an underlying palpable mass
- Duration ≤6 months
- Erythema occupying ≥1/3 of the breast
- Pathological confirmation of invasive carcinoma (required but not specific)
A critical pitfall: an underlying palpable mass is often absent (62% of cases have a palpable mass, meaning 38% do not), which can lead to misdiagnosis as mastitis 1, 2.
Histopathologic Morphology
Key Pathologic Features
Dermal lymphovascular tumor emboli are pathognomonic when present on skin punch biopsy, but are not required for diagnosis 1. The international expert panel strongly recommends obtaining at least two skin punch biopsies in all suspected cases 1.
The histologic characteristics include 3, 4:
- Ductal phenotype is most common
- Emboli composed of pleomorphic cells with high nuclear grade
- Emboli located in papillary and reticular dermis overlying the breast
- No specific histologic tumor type is associated with IBC 5
- Histologic grade 2-3 predominates 4
Variant Morphology
IBC can arise from various histologic subtypes. When lobular features are present (14% of cases), they typically show 4:
- Variant morphologic features in 92% of pure invasive lobular carcinoma cases
- Pleomorphic apocrine features (50%)
- Solid growth pattern (25%)
- Negative or aberrant E-cadherin, p120, and beta-catenin staining
Dermal Involvement Patterns
Two patterns of skin involvement occur 4:
- Dermal lymphovascular invasion: 46% of cases
- Direct dermal invasion: 50% of cases
Cytologic Morphology (Fine-Needle Aspiration)
FNA specimens are characteristically paucicellular with distinctive features 6:
- Malignant cells predominantly in tight, three-dimensional clusters
- Lack of cellular discohesiveness (unlike conventional breast carcinoma)
- Large cells with nuclear irregularity and increased nuclear-to-cytoplasmic ratio
- Fragments of fibrous or adipose tissue
- Multiple passes required to obtain diagnostic material
This differs significantly from typical breast carcinoma aspirates, which show more dispersed individual cells.
Imaging Morphology
Mammographic Features 2
- Skin thickening: 84%
- Trabecular thickening: 81%
- Asymmetric focal density: 61%
- Microcalcifications: 56%
- Diffusely increased density: 37%
- Mass: only 16% (often absent)
Ultrasound Features 2
- Skin thickening: 96%
- Solid mass: 80%
- Parenchymal echogenicity changes: 73%
- Axillary lymphadenopathy: 73%
- Dilated lymphatic channels: 68%
MRI Features 7
MRI is superior to mammography for detecting the primary lesion (98% vs 68%, p<0.0001). Key features include:
- Multiple small, confluent masses: 82% of cases with masses
- Irregular mass margins: 75%
- Heterogeneous internal enhancement: 82%
- Delayed washout kinetics: 85%
- Global skin thickening: 93%
Molecular/Receptor Morphology
The receptor profile shows distinct patterns 3, 4:
- Frequent loss of hormone receptors (ER/PR)
- ERBB2/HER2 overexpression is debated but appears more prevalent than in non-IBC
- TP53 overexpression is common
- When ER+/HER2-: 50% of lobular variant cases
Tumor Microenvironment
The microenvironment is complex and contributes to aggressive behavior 3:
- Macrophages and monocytes
- Predominantly T CD8+ lymphocytes
- Extensive blood vessel involvement
- Altered extracellular matrix
Critical Diagnostic Pitfall
IBC is not defined by a specific histologic pattern but by the combination of clinical presentation and pathologic confirmation of invasive carcinoma. The absence of dermal lymphovascular emboli does not exclude the diagnosis if clinical criteria are met 1. This is why the international expert panel emphasizes that diagnosis should remain clinical with pathological confirmation, rather than requiring specific pathologic features.